184 related articles for article (PubMed ID: 17625308)
41. The use of gabexate mesylate and ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Yoo YW; Cha SW; Kim A; Na SY; Lee YW; Kim SH; Lee HIe; Lee YJ; Yang HW; Jung SH
Gut Liver; 2012 Apr; 6(2):256-61. PubMed ID: 22570757
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological prevention of post-ERCP pancreatitis: which therapy is best?
Mariani A
JOP; 2003 Jan; 4(1):68-74. PubMed ID: 12555018
[TBL] [Abstract][Full Text] [Related]
43. A randomized control study to investigate the application of Ulinastatin-containing contrast medium to prevent post-ERCP pancreatitis.
Wang J; Su J; Lu Y; Zhou H; Gong B
Hepatogastroenterology; 2014; 61(136):2391-4. PubMed ID: 25699389
[TBL] [Abstract][Full Text] [Related]
44. Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography.
Lieb JG; Draganov PV
World J Gastroenterol; 2007 Jul; 13(26):3567-74. PubMed ID: 17659706
[TBL] [Abstract][Full Text] [Related]
45. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
Poon RT; Fan ST
JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
[TBL] [Abstract][Full Text] [Related]
46. Complications of endoscopic sphincterotomy and their prevention.
Huibregtse K
N Engl J Med; 1996 Sep; 335(13):961-3. PubMed ID: 8782505
[No Abstract] [Full Text] [Related]
47. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial.
Wang ZK; Yang YS; Cai FC; Wang YH; Shi XL; Ding C; Li W
Chin Med J (Engl); 2013 Jul; 126(13):2403-8. PubMed ID: 23823808
[TBL] [Abstract][Full Text] [Related]
48. Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination?
Pezzilli R; Gabbrielli A; Labate AM; D'Alessio P; Barakat B; Costamagna G; Dibenedetti F; Massa M; Merlini G; d'Eril GM
Hepatogastroenterology; 2003; 50(51):851-5. PubMed ID: 12828103
[TBL] [Abstract][Full Text] [Related]
49. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
Bai Y; Gao J; Shi X; Zou D; Li Z
Pancreatology; 2008; 8(4-5):504-9. PubMed ID: 18765955
[TBL] [Abstract][Full Text] [Related]
50. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial.
Concepción-Martín M; Gómez-Oliva C; Juanes A; Díez X; Prieto-Alhambra D; Torras X; Sainz S; Villanueva C; Farre A; Guarner-Argente C; Guarner C
Endoscopy; 2014 Oct; 46(10):851-6. PubMed ID: 24977398
[TBL] [Abstract][Full Text] [Related]
51. Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Bai Y; Xu C; Yang X; Gao J; Zou DW; Li ZS
Endoscopy; 2009 Aug; 41(8):690-5. PubMed ID: 19670137
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of gabexate mesilate in preventing post endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis of randomized clinical trials.
Xie J; Li L
J Formos Med Assoc; 2021 Sep; 120(9):1796-1797. PubMed ID: 33895063
[No Abstract] [Full Text] [Related]
53. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial.
Poon RT; Yeung C; Lo CM; Yuen WK; Liu CL; Fan ST
Gastrointest Endosc; 1999 May; 49(5):593-8. PubMed ID: 10228257
[TBL] [Abstract][Full Text] [Related]
54. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
[TBL] [Abstract][Full Text] [Related]
55. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis.
Das A; Singh P; Sivak MV; Chak A
Gastrointest Endosc; 2007 Jun; 65(7):960-8. PubMed ID: 17331513
[TBL] [Abstract][Full Text] [Related]
56. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
Lee KT; Lee DH; Yoo BM
Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
Sherman S; Alazmi WM; Lehman GA; Geenen JE; Chuttani R; Kozarek RA; Welch WD; Souza S; Pribble J;
Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):462-72. PubMed ID: 19231487
[TBL] [Abstract][Full Text] [Related]
58. Short-term prophylactic prevention of post-ERCP pancreatitis.
Masci E; Mariani A
Gastrointest Endosc; 2003 Nov; 58(5):816. PubMed ID: 14997914
[No Abstract] [Full Text] [Related]
59. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
[TBL] [Abstract][Full Text] [Related]
60. [Effects of rectal indomethacin in the prevention of post-ERCP acute pancreatitis].
Döbrönte Z; Toldy E; Márk L; Sarang K; Lakner L
Orv Hetil; 2012 Jun; 153(25):990-6. PubMed ID: 22714033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
